Yaqi Duan Selected Research

Yaqi Duan Research Topics

Disease

13	Neoplasms (Cancer) 09/2023 - 01/2016
3	Insulinoma 01/2022 - 01/2022
3	COVID-19 01/2022 - 11/2020
3	Myocardial Infarction 12/2017 - 11/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2019 - 10/2016
1	Large Cell Carcinoma 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Triple Negative Breast Neoplasms 10/2021
1	Inflammation (Inflammations) 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Atherosclerosis 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Adenocarcinoma of Lung 01/2019
1	Carcinogenesis 01/2018
1	Seizures (Absence Seizure) 04/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Hemangiosarcoma (Angiosarcoma) 01/2016
1	Capillary Hemangioma 01/2016
1	Hypoxia (Hypoxemia) 09/2010
1	Necrosis 07/2010
1	Heart Failure 10/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2016
2	Cyclin D1IBA 10/2018 - 01/2016
2	Stem Cell FactorIBA 12/2017 - 01/2016
1	Anaplastic Lymphoma KinaseIBA 09/2023
1	Keratins (Keratin)IBA 09/2023
1	DesminIBA 09/2023
1	MyogeninIBA 09/2023
1	SynaptophysinIBA 01/2022
1	Chromogranin AIBA 01/2022
1	venetoclaxIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AntigensIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Annexin A5IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	CarbohydratesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 01/2022
1	Semaphorins (Semaphorin)IBA 12/2021
1	ImmunosorbentsIBA 12/2021
1	EnzymesIBA 12/2021
1	CD3 ComplexIBA 10/2021
1	FibrinIBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2020
1	CathepsinsIBA 11/2020
1	fasudil (AT 877)IBA 01/2020
1	CXC ChemokinesIBA 01/2020
1	rho-Associated KinasesIBA 01/2020
1	MTOR InhibitorsIBA 11/2019
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	CateninsIBA 10/2018
1	4,6- dimorpholino- N- (4- nitrophenyl)- 1,3,5- triazin- 2- amineIBA 07/2017
1	LigandsIBA 07/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2017
1	Formaldehyde (Formol)FDA Link 11/2016
1	ParaffinIBA 11/2016
1	ErbB Receptors (EGF Receptor)IBA 11/2016
1	TRAM 34IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 01/2016
1	ChemokinesIBA 11/2015
1	Chemokine CXCL12IBA 11/2015
1	CXCR ReceptorsIBA 09/2010
1	myocardinIBA 09/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2010
1	Hematoxylin (Haematoxylon)IBA 07/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 10/2016
1	Modified Radical Mastectomy (Mastectomy, Modified) 12/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Cardiomyoplasty 10/2006